Top Markets
Coin of the day
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
Clasificación en acciones #14759
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
Precio por acción
$2.35
Capitalización bursátil
$394.12M
Cambio (1 día)
-1.07%
Cambio (1 año)
-64.75%
País
TW
Comercio Lumosa Therapeutics Co., Ltd. (6535)

Categoría

Historial del precio de la acción de Lumosa Therapeutics Co., Ltd. (6535)
Precio más alto de cierre: $2.35 el 2026-09-01

Precio más bajo de cierre: $1.29 el 2015-07-01
Historial del precio de la acción de Lumosa Therapeutics Co., Ltd. desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -11.24%
2025 -7.99%
2024 206.71%
2023 67.55%
2022 -8.12%
2021 11.91%
2020 4.84%
2019 18.82%
2018 1.29%
2017 -28.93%
2016 -36.03%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$745.22 4.45%
CH